Quarterly report pursuant to Section 13 or 15(d)

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)

v3.2.0.727
Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2015
Notes Tables  
Schedule of Franchisor Disclosure [Table Text Block]
    Three Months Ended
June 30,		   Six Months Ended
June 30,
Franchised clinics:   2015   2014   2015   2014
 Clinics open at beginning of period     241       192       242       175  
 Opened during the period     10       23       23       41  
 Acquired during the period     (11 )     -       (21 )     -  
 Closed during the period     (1 )     -       (5 )     (1 )
 Clinics in operation at the end of the period     239       215       239       215  
                                 
 Franchises sold but not yet operational     230       250       230       250  
    Three Months Ended
June 30,		   Six Months Ended
June 30,
Corporate owned or managed clinics:   2015   2014   2015   2014
 Clinics open at beginning of period     12       -       4       -  
 Acquired during the period     11       -       21       -  
 Closed during the period     -       -       (2 )     -  
 Clinics in operation at the end of the period     23       -       23       -  
                                 
 Total clinics in operation at the end of the period     262       215       262       215  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
    Three Months Ended
June 30,		   Six Months Ended
June 30,
    2015   2014   2015   2014
                 
Net loss   $ (1,855,870 )   $ (133,749 )   $ (3,759,593 )   $ (261,646 )
                                 
Weighted average common shares outstanding - basic     9,768,230       4,819,902       9,734,115       4,815,754  
Effect of dilutive securities:                                
Stock options     -       -       -       -  
Weighted average common shares outstanding - diluted     9,768,230       4,819,902       9,734,115       4,815,754  
                                 
Basic and diluted loss per share   $ (0.19 )   $ (0.03 )   $ (0.39 )   $ (0.05 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
    Three Months Ended
June 30,		   Six Months Ended
June 30,
    2015   2014   2015   2014
Unvested restricted stock     453,846       116,818       453,846       116,818  
Stock options     376,275       271,895       376,275       271,895  
Warrants     90,000       -       90,000       -